Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Epilepsy Behav. 2018 Feb 21;81:125–127. doi: 10.1016/j.yebeh.2017.12.015

Figure 2.

Figure 2

The Lafora Epilepsy Cure Initiative (LECI) is funded by NIH grant NS097197. The primary investigator’s and projects for the grant are Drs. Gentry - Project #1: Personalized diagnosis - defining how glycogen metabolism and proteostasis impact LD; Minassian - Project #2: Genome editing, mRNA suppression and glycogen chain termination to inhibit glycogen storage as therapy for LD; Roach - Project #3: Suppressing glycogen storage with small molecule inhibitors as a therapeutic approach to LD; and Guinovart - Project #4: Defining the therapeutic window for the treatment of LD.